Alzamend Neuro Inc expected to post a loss of 23 cents a share - Earnings Preview
Alzamend Neuro Inc <ALZN.OQ> expected to post a loss of 23 cents a share - Earnings Preview
Alzamend Neuro Inc ALZN.OQ ALZN.O is expected to show no change in quarterly revenue when it reports results on December 7 (estimated) for the period ending October 31 2026
LSEG's mean analyst estimate for Alzamend Neuro Inc is for a loss of 23 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts had risen by about 16.4% in the last three months.
Wall Street's median 12-month price target for Alzamend Neuro Inc is $26.00, about 1,429.4% above its last closing price of $1.70
This summary was machine generated September 11 at 20:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Alzamend Neuro
See all newsAlzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 23 cents a share - Earnings Preview
Alzamend Neuro Inc expected to post a loss of 56 cents a share - Earnings Preview
Alzamend Neuro Inc reports results for the quarter ended April 30 - Earnings Summary
Alzamend Neuro Inc expected to post a loss of 67 cents a share - Earnings Preview